FDA
-
-
-
-
-
-
-
Corcept Therapeutics Incorporated Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CORT
-
-
-
-
-
-
-
CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm
-
-
-
-
-
-
-
Portnoy Law Firm Announces Class Action on Behalf of Corcept Therapeutics Incorporated Investors
-
-
-
-
-
-
-
Corcept Therapeutics (CORT) PT Lowered to $67 at H.C. Wainwright
-
-
-
-
-
-
-
CORT INVESTIGATION: Corcept Therapeutics Investors Should Contact Block & Leviton LLP To Potentially Recover Losses
-
-
-
-
-
-
-
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
-
-
-
-
-
-
-
FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

